The store will not work correctly when cookies are disabled.
N-(3-bromophenyl)-2-phenylmethanesulfonylaminoacetamide
ID: ALA4542338
PubChem CID: 32442164
Max Phase: Preclinical
Molecular Formula: C15H15BrN2O3S
Molecular Weight: 383.27
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CNS(=O)(=O)Cc1ccccc1)Nc1cccc(Br)c1
Standard InChI: InChI=1S/C15H15BrN2O3S/c16-13-7-4-8-14(9-13)18-15(19)10-17-22(20,21)11-12-5-2-1-3-6-12/h1-9,17H,10-11H2,(H,18,19)
Standard InChI Key: HEUZAFXSCKUENO-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
41.0659 -9.6577 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.6615 -8.9520 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
40.2525 -9.6551 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.8329 -8.9643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8317 -9.7838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5398 -10.1928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2494 -9.7834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2466 -8.9607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5380 -8.5554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9528 -8.5494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3682 -8.5441 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.0774 -8.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.7836 -8.5388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4928 -8.9447 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.7805 -7.7216 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.1990 -8.5334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.9054 -8.9415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.6111 -8.5309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.6085 -7.7129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.8942 -7.3071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1915 -7.7200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.3201 -8.9372 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 2 1 0
2 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
18 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 383.27 | Molecular Weight (Monoisotopic): 381.9987 | AlogP: 2.51 | #Rotatable Bonds: 6 |
Polar Surface Area: 75.27 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.77 | CX Basic pKa: ┄ | CX LogP: 2.25 | CX LogD: 2.23 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.81 | Np Likeness Score: -1.97 |
References
1. (2014) Serine racemase inhibitor, |